Biomab EGFR 50mg Injection consists of the active Nimotuzumab. It is a monoclonal antibody used in cancer treatment.  It has been approved for the treatment of head and neck cancer, as well as for certain types of brain cancer. This medication is typically used with other cancer treatments, such as chemotherapy and radiation therapy. The drug effectively improves overall survival and disease-free survival in some cancer patients. However, like all cancer treatments, it can have side effects, including allergic reactions, skin rashes, and flu-like symptoms. transplant.

There are no absolute contraindications to Biomab EGFR 50mg Injection, but there are some precautions and potential contraindications to consider. For example, patients with a history of severe allergic reactions or hypersensitivity to it or its components should not receive the medication. Additionally, patients with certain medical conditions, such as severe liver or kidney disease, may need to be monitored closely or have their dosages adjusted.

• Head and neck cancer
• Certain types of brain cancer
• Esophageal cancer

The therapeutic effect of Biomab EGFR 50mg Injection is primarily focused on its ability to target and bind to the epidermal growth factor receptor (EGFR) found on many cancer cells. Doing so can block the growth and spread of cancer cells, ultimately leading to improved patient outcomes. One of the advantages is its targeted therapy approach, which allows it to target cancer cells while minimizing damage to healthy cells specifically. This can help to reduce side effects and improve the overall quality of life for cancer patients undergoing treatment.

Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Biomab EGFR 50mg Injection and reduce effectiveness by causing undesirable side effects.

• Biomab EGFR 50mg Injection should be stored in a refrigerator at a temperature between 2°C to 8°C (36°F to 46°F).
• Not need to be frozen, as this can damage its efficacy.
• Once a vial is opened, it should be used immediately.
• If the drug is not used immediately, it can be stored at room temperature for 4 hours. After 4 hours, any remaining drug should be discarded.
• Keep out of reach of children and pets.

Biomab EGFR 50mg Injection is an injectable medication that a healthcare professional administers. It is typically given as an intravenous injection. The dose and frequency will depend on the type of cancer being treated, the patient's overall health, and other medications the patient may be taking.  If you miss a dose, contact your healthcare provider as soon as possible. Your healthcare provider may recommend rescheduling your next dose or adjusting your dosing schedule. Do not double the dose to make a missed dose.

Like all medications, Biomab EGFR 50mg Injection can cause side effects, although not everyone who takes it will experience them. 

Serious:

• Allergic reactions
• Difficulty breathing
• Swelling of the face or throat, or hives
• Infusion reactions (fever, chills, or low blood pressure)
• Chest pain
• Irregular heartbeat
• Lung problems (cough or shortness of breath)
• Liver problems (jaundice or abdominal pain)

Common: 

• Skin rash
• Diarrhea
• Nausea and vomiting
• Fatigue
• Headache
• Fever
• Pain at the injection site

It is important to carefully read the medication label before taking Biomab EGFR 50mg Injection. Follow the instructions provided by your healthcare provider and the label, such as how much to take and how often. Your healthcare provider can provide more information on the risks and benefits of it and can help you determine if it is the right treatment option for you. It is important to report any side effects you may experience during treatment to your healthcare provider. Pregnancy and breastfeeding are not recommended while taking this medication. Before starting it or any other medication, inform your healthcare provider of any allergies or medications you are taking. This can help prevent any potential interactions or adverse effects.

1. KD Tripathi, Essentials of Medical Pharmacology, 7th edition, Jaypee Brothers Medical Publishers (P) Ltd.; 2013, 893-894.
2. Goodman & Gilman's The Pharmacological Basis of Therapeutics (Brunton, L.L., Chabner, B.A., and Knollmann, B.C., eds.). Biomab EGFR 50mg Injection. 13th edition, 1461-1463.
3. Bespons Pvt Ltd,  U.S. Food and Drug Administration., Highlights of prescribing information - Biomab EGFR 50mg Injection, [Last updated: March 2020],[10 April 2023], Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761040s000lbl.pdf
4. S.H. Ibbotson, R.S. Dawe, Skin Disease, Davidson’s Principles & Practice of Medicine, 22nd Edition, 2014, 1249-1305